IGC Pharma, Inc. (IGC) Class Action Lawsuit (November 2018)
Closed8:18cv3396 • November 2, 2018
Class Period Start
September 25, 2018
Class Period End
January 25, 2019
PSLRA Deadline
January 2, 2019
Case Allegations
10b5
Statutes of Repose
Sep 25, 2021
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
March 14, 2022
Settlement Fund
$1,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or otherwise acquired the publicly traded common stock of India Globalization Capital, Inc. (“IGC” or the “Company”) during the period between September 26, 2018 and October 26, 2018, both dates inclusive.
Claim Administrator
Strategic Claims Services
India Globalization Capital, Inc. Securities Litigation c/o Strategic Claims Services 600 N. Jackson St., Ste. 205 P.O. Box 230
Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://www.strategicclaims.net/igc/Hearing Date
April 13, 2022
Opt-out Deadline
March 23, 2022
Settlement Note
Download hereProof Of Claim
Download hereDocket History
Dec 2, 2022
Disbursement Approved (opens in a new tab)
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Apr 13, 2022
Final Approval of Settlement (opens in a new tab)
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Dec 27, 2021
Preliminary Approval of Settlement (opens in a new tab)
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Dec 27, 2021
Proof of Claim Form (opens in a new tab)
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Oct 20, 2021
Feb 16, 2021
Feb 16, 2021
Jan 29, 2021
Motion to Dismiss Denied (opens in a new tab)
The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.
Oct 11, 2019
Motion to Dismiss (opens in a new tab)
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
May 13, 2019
First Amended Complaint (opens in a new tab)
A new complaint has been filed on behalf of certain investors in IGC Pharma, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Feb 28, 2019
Appointment of Lead Plaintiff (opens in a new tab)
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Nov 2, 2018
First Filed Complaint (opens in a new tab)
A securities fraud class action complaint has been filed on behalf of certain investors in IGC Pharma, Inc..